Advertisement

Topics

Abzena Selects Sartorius Stedim Biotech To Equip U.S. Development And Manufacturing Sites

04:00 EDT 17 May 2018 | Pharmaceutical Processing

Abzena has selected Sartorius Stedim to equip its integrated CDMO facilities in Bristol, PA (development and GMP manufacture of antibody drug conjugates) and San Diego, CA (development and GMP manufacture of monoclonal antibodies and other recombinant proteins).
Contributed Author: 
Abzena plc

Original Article: Abzena Selects Sartorius Stedim Biotech To Equip U.S. Development And Manufacturing Sites

NEXT ARTICLE

More From BioPortfolio on "Abzena Selects Sartorius Stedim Biotech To Equip U.S. Development And Manufacturing Sites"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...